Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Opsoclonus-Myoclonus Syndrome

fluorodeoxyglucose f18 has been researched along with Opsoclonus-Myoclonus Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, HJ; Jeong, YJ; Lim, ST; Na, CJ; Sohn, MH1
Boegle, R; Dieterich, M; Ertl, M; Eulenburg, PZ; Kim, JS; Oh, SY1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Opsoclonus-Myoclonus Syndrome

ArticleYear
18F-FDG PET/CT Brain Imaging on a Patient With Paraneoplastic Opsoclonus-Myoclonus Syndrome Arising out of a Mature Cystic Teratoma.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:2

    Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Opsoclonus-Myoclonus Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Teratoma; Tomography, X-Ray Computed; Young Adult

2016
Longitudinal multi-modal neuroimaging in opsoclonus-myoclonus syndrome.
    Journal of neurology, 2017, Volume: 264, Issue:3

    Topics: Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Multimodal Imaging; Neural Pathways; Opsoclonus-Myoclonus Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Rest; Young Adult

2017